Merck Stock Target Price and Analyst Consensus

MRK -  USA Stock  

USD 81.66  0.51  0.63%

The current analyst and expert consensus on Merck is Buy with 6 hold recommendations. The current projected Merck target price consensus is 93.55 with 11 analyst opinions. One of the most common ways Merck Company analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Merck vendors, executives, and/or customers. Merck recommendation module provides expert sentiment on the projected Merck Company target price to derive its highest and lowest estimates based on target price standard deviation of 8.116. Additionally, see Macroaxis Advice on Merck to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.

Merck Analyst Recommendations 

 
Refresh
The current Gross Profit is estimated to increase to about 33.6 B. The current Profit Margin is estimated to increase to 0.15. Merck Cash and Equivalents is decreasing as compared to previous years. The last year's value of Cash and Equivalents was reported at 8.05 Billion. The current Shareholders Equity is estimated to increase to about 30.8 B, while Current Assets are projected to decrease to under 27.3 B.

Merck Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Merck target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Merck target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions13
Lowered Outlook0
Raized Outlook0
Buy
Most Merck analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Merck stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Merck Company, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Merck Target Price Projection

Merck's current and average target prices are 81.66 and 93.55, respectively. The current price of Merck is the price at which Merck Company is currently trading. On the other hand, Merck's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Merck Market Quote on 26th of October 2021

Low Price79.95Odds
High Price81.72Odds

81.66

Target Price

Analyst Consensus On Merck Target Price

Low Estimate79.0Odds
High Estimate107.0Odds
Number of Analysts11
Standard Deviation8.116

93.545

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Merck Company and the information provided on this page.

Merck Analyst Ratings

Merck's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Merck stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Merck's financials, market performance, and future outlook by experienced professionals. Merck's historical ratings below, therefore, can serve as a valuable tool for investors.

Average Consensus Estimates

About Merck Target Price Projections

Merck's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Merck Company and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Merck depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Merck Company
 2018 2019 2020 2021 (projected)
Long Term Debt to Equity0.740.881.01.08
Interest Coverage19.3418.7410.2411.47

Additional Merck Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Merck is a key component of Merck valuation and have some predictive power on the future returns of a Merck.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Merck's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Merck in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
80.0881.5883.08
Details
Intrinsic
Valuation
LowReal ValueHigh
74.2675.7689.83
Details
Naive
Forecast
LowNext ValueHigh
75.5477.0578.55
Details
Earnings
Estimates (7)
LowProjected EPSHigh
5.475.515.55
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Merck. Your research has to be compared to or analyzed against Merck's peers to derive any actionable benefits. When done correctly, Merck's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Merck Company.

Currently Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Cars
Invested over 50 shares
Artificial Intelligence
Invested few shares
Additionally, see Macroaxis Advice on Merck to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Merck Company information on this page should be used as a complementary analysis to other Merck's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Merck Stock analysis

When running Merck Company price analysis, check to measure Merck's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck is operating at the current time. Most of Merck's value examination focuses on studying past and present price action to predict the probability of Merck's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Merck's price. Additionally, you may evaluate how the addition of Merck to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
The data published in Merck's official financial statements usually reflect Merck's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Merck Company. For example, before you start analyzing numbers published by Merck accountants, it's critical to develop an understanding of what Merck's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Merck's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Merck's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Merck's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Merck Company. Please utilize our Beneish M Score to check the likelihood of Merck's management to manipulate its earnings.